Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, FDA

MezLighttm Granted FDA Registration


MADISON, Wis., July 27, 2021 /PRNewswire/ -- MezLight LLC is excited to announce the launch of their revolutionary surgical lighting system to provide surgeons with a bright, sterile, and reusable solution for focused light.

Good lighting is an essential element in performing surgical procedures efficiently and accurately to produce the best possible patient outcome. The MezLight was invented by University of Wisconsin transplant surgeon Josh Mezrich in response to his own experience, and that of his colleagues, with the need for better lighting in the operating room (OR).

The current standard for bright, focused lighting is the surgeon's headlight which has numerous downsides including physical discomfort, encouraging poor ergonomic posture, lack of sterility, and contribution to physician distraction during a procedure. Perhaps the most serious is the role headlights make to the already physically demanding activity of surgery. Holding a poor ergonomic posture to keep the headlight trained on the surgical site can ultimately lead to serious physical injury and chronic pain for the surgeon.

MezLight's surgeon-centric design approach focuses on the wellbeing of the surgeon as a key element in patient outcomes. According to MezLight inventor and co-founder Josh Mezrich his guiding tenet was "I don't want to change how people operate; I want to help them operate better".

The MezLight attaches to the OR table rail using a standard Clark Socket and delivers the light intensity and illumination performance of a surgeon's headlight without residing on the surgeon's head. MezLight's patent pending flexible neck design allows for use in a wide variety of procedures and provides increased angular cavity illumination not possible with headlights and overhead lights.

Because the MezLight is designed to be sterilized in an autoclave surgeons can control and manipulate their lighting without the need for a towel or sterile sleeve. Interruptions of and distractions to surgical workflow are reduced by the ability of the surgeon to quickly position and reposition the light. The MezLight is FDA registered and available now, details for trialing and ordering a MezLight can be found at www.mezlight.com.

About MezLighttm LLC
MezLight LLC is a privately held Madison, WI based company designing device solutions that put the wellbeing of the surgeon at the center of innovation. Visit www.mezlight.com for more information.

Contact:
MezLight LLC
[email protected]
877.404.2248

SOURCE MezLight LLC


These press releases may also interest you

at 06:30
Boston Scientific Corporation generated net sales of $3.856 billion during the first quarter of 2024, growing 13.8 percent on a reported basis, 15.0 percent on an operational1 basis and 13.1 percent on an organic2 basis, all compared to the prior...

at 06:28
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Pharma Parenteral Packaging Market ? By Drug Type (Small Molecules, Biologics, Vaccines, Biosimilars, & Others), By Product Type (Bottles, Ampoules,...

at 06:15
Overall 8.46 Average Revised Venous Clinical Severity Score (rVCSS) Improvement Per Patient for Patients Showing Clinical Meaningful Benefit (rVCSS Improvement ≥ 3 Points) including:9.29 Points for Patients at the Two-Year Milestone8.08 Points...

at 06:10
Thermo Fisher Scientific Inc. , the world leader in serving science, will hold its 2024 Investor Day on Thursday, September 19, starting at 9:00 a.m. (ET) in New York City. The format will feature presentations by members of Thermo Fisher...

at 06:05
Thermo Fisher Scientific Inc. , the world leader in serving science, today reported its financial results for the first quarter ended March 30, 2024. First Quarter 2024 Highlights First quarter revenue was $10.34 billion. First quarter GAAP...

at 06:05
Biodesix, Inc. , a leading diagnostic solutions company with a focus in lung disease, announced today that it will release financial results for the first quarter ended March 31, 2024 after the close of trading on Wednesday, May 8. Biodesix's...



News published on and distributed by: